New Delhi, Nov 18 : The National Action Plan for Vulture Conservation, 2020-25 was recently approved by National Board for Wild life. The plan suggests that new veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAID) should be tested on vultures before they are commercially released.
The new plan automatically removes veterinary use of a drug if it is found to be toxic to vultures. This is to be done with the help of Drugs Controller General of India. Under the plan, every state will host at least one vulture safe zone to conserve the remnant population of vultures in the state.
These centres will facilitate conservation and breeding of vultures. A coordinated Nation-wide vulture counting is to be conducted by the Bombay Natural History Society, Forest Department, non-profit organisations, Research Institute, etc. These countings are to be conducted at regular intervals.
The Vulture Multi-Species Action Plan was adopted at the Convention for the Conservation of Migratory Species (CMS) held in 2017. The first strategy of the plan was launched at the CMS COP 13 held in Gandhinagar, in Feb 2020. The major objectives of the plan are to reduce the mortality caused due to unintentional toxic substances, to reduce mortality due to NSAID, to halt the trade of vulture parts and to stop poisoning by poaching activities.
The Vulture conservation programme is a part of the UNEP and every member country is expected to create a National vulture Task Force. Each of the member countries have to create the report of success of the project in 2029.